BR100 No Change (0%)
BR30 No Change (0%)
KSE100 Increased By (0.39%)
KSE30 Increased By (0.46%)
AGHA 6.75 Increased By ▲ 0.07 (1.05%)
BECO 4.42 Increased By ▲ 0.05 (1.14%)
BML 57.00 Decreased By ▼ -0.32 (-0.56%)
BOP 30.50 Increased By ▲ 0.15 (0.49%)
CNERGY 13.18 Increased By ▲ 0.06 (0.46%)
CSIL 5.41 No Change ▼ 0.00 (0%)
FCCL 52.95 Increased By ▲ 0.16 (0.3%)
FFL 14.75 Increased By ▲ 0.03 (0.2%)
FNEL 1.14 Increased By ▲ 0.02 (1.79%)
KEL 6.13 Increased By ▲ 0.04 (0.66%)
KOSM 5.90 Increased By ▲ 0.17 (2.97%)
LOTCHEM 26.65 Increased By ▲ 0.19 (0.72%)
MLCF 93.63 Increased By ▲ 0.47 (0.5%)
NBP 165.50 Increased By ▲ 0.84 (0.51%)
NCPL 55.89 Increased By ▲ 0.23 (0.41%)
NPL 61.10 Decreased By ▼ -0.06 (-0.1%)
OGDC 317.00 Increased By ▲ 0.27 (0.09%)
PACE 9.90 Increased By ▲ 0.03 (0.3%)
PAEL 35.63 No Change ▼ 0.00 (0%)
PIBTL 14.85 Increased By ▲ 0.17 (1.16%)
PPL 227.00 Increased By ▲ 0.09 (0.04%)
PRL 93.80 Increased By ▲ 0.78 (0.84%)
PTC 61.00 Increased By ▲ 0.74 (1.23%)
SSGC 23.70 Decreased By ▼ -0.11 (-0.46%)
TBL 8.70 Decreased By ▼ -0.05 (-0.57%)
TELE 7.81 Increased By ▲ 0.01 (0.13%)
TPL 22.35 Increased By ▲ 0.12 (0.54%)
TPLP 12.97 No Change ▼ 0.00 (0%)
TREET 22.37 Increased By ▲ 0.21 (0.95%)
TRG 57.00 Increased By ▲ 0.44 (0.78%)
Markets

Brent oil still targets $110.02

Published Updated

brent-oilSINGAPORE: A bearish target at $110.02 per barrel remains unchanged for Brent oil, as indicated by its wave pattern and a Fibonacci projection analysis.

The contract is still riding on a downward wave c, unfolding towards its 100 percent Fibonacci projection level at $110.02.

A Fibonacci retracement analysis on the rise from the Nov. 5, 2012 low of $104.76 to $119.17 reveals oil has cleared a support at $111.97, the 50 percent level, and the next support is at $110.26, close to $110.02.

A rebound may not occur until oil reaches $110.02.

No information in this analysis should be considered as being business, financial or legal advice. Each reader should consult his or her own professional or other advisers for business, financial or legal advice regarding the products mentioned in the analyses.

Copyright Reuters, 2013

Comments

Comments are closed for this article.